Abridge, an AI start-up automating medical notes, has protected a $300 million Series E at a $5.3 billion valuation, according to the Wall Street Journal.
The round, led by Andreessen Horowitz with involvement from Khosla Ventures, follows the business $250 million February fundraise at a $2.75 billion valuation.The 7-year-old Abridge is extensively thought about to be the leader in the significantly congested AI-powered medical scribe market, mainly due to its early entryand integration with Epic Systems, the dominant health record software.In Q1, Abridge reached $117 million in contracted annual repeating income (a metric that consists of all signed repeating contacts, including from consumers that have actually still not been onboarded), The Information reported last month.Along with the fundraise, Abridge revealed that it is broadening into converting medical notes from client appointments into AI-powered medical codes, an offering that makes the business straight competitive with startups like CodaMetrix and a feature from its partner Epic Systems.Abridge, which was established by cardiologist Shiv Rao, claims that its AI scribe technology is utilized by over 150 of the largest health systems in the U.S.